Valuation: Genus plc

Capitalization 2.03B 2.76B 2.33B 2.12B 3.76B 250B 3.91B 24.7B 9.81B 121B 10.36B 10.15B 422B P/E ratio 2026 *
46.4x
P/E ratio 2027 * 37.7x
Enterprise value 2.2B 2.99B 2.52B 2.3B 4.08B 271B 4.23B 26.75B 10.62B 131B 11.22B 10.99B 457B EV / Sales 2026 *
3.1x
EV / Sales 2027 * 2.94x
Free-Float
99.25%
Yield 2026 *
1.09%
Yield 2027 * 1.18%
1 day-0.08%
1 week-0.16%
Current month-4.11%
1 month+15.21%
3 months+23.67%
6 months+16.54%
Current year+16.76%
1 week 2,985
Extreme 2985
3,190
1 month 2,698.19
Extreme 2698.194
3,190
Current year 2,490
Extreme 2490
3,190
1 year 1,548
Extreme 1548
3,228.8
3 years 1,424
Extreme 1424
3,228.8
5 years 1,424
Extreme 1424
6,310
10 years 1,323
Extreme 1323
6,310
Manager TitleAgeSince
Chief Executive Officer 57 30/06/2023
Chief Operating Officer - 31/12/2010
Chief Tech/Sci/R&D Officer - 14/07/2019
Director TitleAgeSince
Director/Board Member 73 31/05/2018
Chairman 69 24/11/2020
Director/Board Member 68 18/11/2025
Change 5d. change 1-year change 3-years change Capi.($)
-0.08%-0.16%+62.21%+10.83% 2.76B
-0.48%+0.73%-12.50%-4.72% 47.61B
-0.10%-2.22%+49.90%+44.95% 38.3B
-0.21%+8.18%+36.90%+61.03% 36.11B
-1.13%-10.96%-13.70%-26.47% 28.31B
-1.05%-1.21%+136.81%+277.09% 18.62B
+7.58%+14.65%+31,531.21%+4,130.93% 15.44B
-0.24%-2.92%+31.47%-4.34% 13.71B
-0.82%-2.62%+50.14%+93.14% 13.28B
-1.44%-6.82%+159.66%+108.92% 13.06B
Average +0.19%-0.89%+3,203.21%+469.14% 22.72B
Weighted average by Cap. -0.02%-0.91%+2,178.53%+327.97%

Financials

2026 *2027 *
Net sales 708M 965M 813M 742M 1.31B 87.41B 1.37B 8.63B 3.42B 42.21B 3.62B 3.54B 148B 735M 1B 844M 769M 1.36B 90.67B 1.42B 8.95B 3.55B 43.79B 3.75B 3.68B 153B
Net income 43.91M 59.85M 50.43M 46M 81.52M 5.42B 84.7M 535M 212M 2.62B 224M 220M 9.15B 54.09M 73.72M 62.11M 56.65M 100M 6.68B 104M 659M 262M 3.22B 276M 271M 11.27B
Net Debt 168M 229M 193M 176M 312M 20.75B 324M 2.05B 813M 10.02B 859M 841M 35.02B 128M 175M 147M 135M 238M 15.85B 248M 1.56B 621M 7.66B 656M 643M 26.76B
Logo Genus plc
Genus plc is a United Kingdom-based animal protein genetics company. The Company supplies breeding animals with desirable characteristics for farmers, enabling them to produce quality meat and milk. Its segments include Genus PIC, Genus ABS and Genus Research and Development. The Genus PIC segment is engaged in the porcine sales business. The Genus ABS segment is engaged in the bovine sales business. Its bovine genetics business sells dairy and beef bull semen and embryos from its superior cattle, which are sold to farmers to breed their cows through artificial insemination. Its porcine genetics business sells genetically superior breeding pigs and semen to farmers, so they can breed commercial pigs with desirable characteristics for pork production. It also provides technical services and advice to farmers, to maximize the performance of its breeding animals in their farms. The Company has supply chain and distribution networks in over 80 countries.
Employees
3,190
Date Price Change Volume
13/02/26 3,030.00 p -0.49% 146,716
12/02/26 3,045.00 p -0.98% 1,110,696
11/02/26 3,075.00 p -1.44% 109,381
10/02/26 3,120.00 p +2.30% 123,877
09/02/26 3,050.00 p +0.49% 110,139
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
30.30GBP
Average target price
30.82GBP
Spread / Average Target
+1.72%

Annual profits - Rate of surprise